View Press Releases
-
CluePoints Wins Growth Award at BVA Private Equity Awards
CluePoints, provider of leading statistical and AI-driven software solutions, has been recognized for its impressive growth at the BVA Private Equity Awards.
Oct 22, 2024
-
Biopharma PEG Provides Advanced PEG Solutions for Drug Development
Biopharma PEG has launched a range of polyethylene glycol (PEG) products for PEGylation, improving drug efficacy. With over 40 approved PEGylated drugs, interest in monodispersed PEGs is growing, as seen with Movantik. Biopharma PEG is dedicated to supporting PEGylated drug development.
Oct 22, 2024
-
DNAnexus Strengthens Leadership Team to Drive Ongoing Product Innovation and Commercial Growth
DNAnexus announced the appointment of Nupura Kolwalkar as chief product officer and Bill Madigan as chief commercial officer.
Oct 21, 2024
-
Ellison Institute of Technology Los Angeles Accelerates Cancer Research with Sapio LIMS
Sapio Sciences, the science-aware™ lab informatics platform, today announced that the Ellison Institute of Technology Los Angeles (EIT Los Angeles), a leading interdisciplinary research center focused on cancer and global health, has successfully deployed Sapio Sciences' Laboratory Information Management System (LIMS) to streamline its complex research operations and accelerate scientific discovery.
Oct 21, 2024
-
KLAS Research Recognizes Proscia For Improving Patient Outcomes
Proscia was named to KLAS Research’s 2024 Emerging Solutions Top 20 list of technologies best positioned to impact the Quadruple Aim of Healthcare. Its Concentriq software platform was selected by healthcare leaders across the United States for improving patient outcomes. Awardees were celebrated at the HLTH USA event in Las Vegas, Nevada.
Oct 21, 2024
-
Optibrium Demonstrates Superior Molecular Docking Method for Small Molecules and Macrocycles
Optibrium, a leading developer of software and AI solutions for molecular design today announced the publication of a peer-reviewed study in the Journal of Computer-Aided Molecular Design, ‘Structure-Based Pose Prediction: Non-cognate Docking Extended to Macrocylic Ligands’. The paper demonstrates that Surflex-Dock can accurately predict the binding conformation and orientation (pose) of unknown (non-cognate) ligands, including macrocycles.
Oct 21, 2024
-
Inizio Medical Appoints Patrick Giordani as SVP, AI Solutions Architect, Underpinning Commitment to Expanding AI Capabilities and Accelerating Innovation
-
Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024
Seer’s Proteograph™ Product Suite reveals new insights into Alzheimer’s pathways, drives population-scale plasma analysis, and captures immune dynamics in xenotransplantation—with additional breakthrough research from collaborators advancing proteomic discovery at scale
Oct 20, 2024
-
Phenomix Sciences and InformedDNA Partner to Advance Genetics-Driven Obesity Care
Launching at HLTH 2024, the groundbreaking partnership offers payers, health systems, employers, and life science organizations access to personalized obesity care and treatment planning based on a patient’s DNA.
Oct 16, 2024
-
DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Platform
DNA Script announces Marc Montserrat's appointment as CEO.
Oct 16, 2024
-
Firstsource positioned a ‘Leader’ in Everest Group's Healthcare Payer Business Process as a Service Solutions PEAK Matrix® Assessment 2024
-
Healthcasts Names Max Baumer Chief Operating Officer & Chief Financial Officer
Healthcasts, the leading online community for healthcare professional consultation and real-world experience, today announced the appointment of Max Baumer, CPA, as Chief Operating Officer and Chief Financial Officer. Baumer has spent over a decade overseeing finance and operations for companies experiencing exceptional growth including large hospital systems and healthcare staffing companies, making him uniquely positioned to bridge financial and operational duties in his role at Healthcasts.
Oct 15, 2024
-
90% of Hospital and Health System Revenue Cycle Leaders Believe GenAI Will Impact Medical Coding Operations
-
CAI Unveils Bold New Brand Identity at ISPE Annual Meeting & Expo
-
1upHealth Launches 1up Patient Connect Product Update to Enhance Patient Data Interoperability Across the Industry
-
Oxford University Hospitals NHS Foundation Trust Propels Digitisation with PhenoTips’ Genomic Health Record.
Oxford University Hospitals NHS Foundation Trust (OUH) accelerates their Digital by Default strategy by harnessing PhenoTips’ cloud-hosted Genomic Health Record to digitise, integrate, and standardise genomic care.
Sep 30, 2024
-
Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities
Sapio Sciences, the science-aware™ lab informatics platform, today announced the addition of new immunogenicity bioanalysis features to its industry-leading lab informatics platform. These new capabilities in the Sapio LIMS (Laboratory Information Management System) and Sapio ELN (Electronic Lab Notebook) solutions streamline testing workflows for detecting anti-drug antibodies (ADA) and neutralizing antibodies (NAb).
Oct 14, 2024
-
PHARMASEAL AND LEDGER RUN FORGE PARTNERSHIP TO ENHANCE CLINICAL BUSINESS OPERATIONS
PHARMASEAL specializes in state-of-the-art trial management software for life sciences (unified CTMS/eTMF) and LEDGER RUN, INC., an innovative technology company focused on optimizing clinical operations in the areas of site budgeting, contracts and payments, announced their partnership today. Through the partnership, PHARMASEAL’S Engility® Platform software Engility CTMS, Engility eTMF and LEDGER RUN'S unique ClinRun™ platform will streamline and enhance clinical operation budgeting and payment processes with an intelligent approach and seamless integration.
Oct 2, 2024
-
Inizio Medical Appoints Matt Wadyka as President, US Medical Affairs
-
Exothera announced the appointment of Cedric Volanti as CEO
Exothera has announced the appointment of a new CEO, Cédric Volanti.
Oct 8, 2024